Opinion: Time to Make The Right Call on Health Care for Texas
July 29, 2015
Robin Armstrong (Houston Chronicle, 7/29), a Houston-based internal medicine physician and National Committeeman for the Republican National Committee, commented that the 340B Drug Discount Program "enables some health care organizations (safety net hospitals, emergency clinics, etc.) or 'covered entities' to obtain pharmaceuticals at a significantly reduced rate, which in turn allows them to provide comprehensive services to rural, uninsured and underserved populations in the U.S. By agreeing to provide these discounts, pharmaceutical companies are then able to participate in Medicaid, which expands their consumer base considerably. ... All of this comes without any new government spending." Armstrong continues, regarding Texas, "Our state will be adversely affected if the 340B program remains in limbo, or if the number of eligible hospitals is cut. Right now, 134 providers in Texas participate in the program, hospitals and clinics that are currently serving the most vulnerable communities with the most serious chronic medical problems."